e-learning
resources
Virtual 2020
Pre-Congress Content
Cardiovascular and pulmonary complications of respiratory infections
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Results of vaccination against pneumococcal infection in patients with chronic heart failure
A. Kraposhina (Krasnoyarsk (Krasnoyarsk), Russian Federation), I. Demko (Krasnoyarsk (Krasnoyarsk), Russian Federation), N. Gordeeva (Krasnoyarsk (Krasnoyarsk), Russian Federation), I. Soloveva (Krasnoyarsk (Krasnoyarsk), Russian Federation), M. Mamaeva (Krasnoyarsk (Krasnoyarsk), Russian Federation), E. Sobko (Krasnoyarsk (Krasnoyarsk), Russian Federation)
Source:
Virtual Congress 2020 – Cardiovascular and pulmonary complications of respiratory infections
Session:
Cardiovascular and pulmonary complications of respiratory infections
Session type:
E-poster session
Number:
1771
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Kraposhina (Krasnoyarsk (Krasnoyarsk), Russian Federation), I. Demko (Krasnoyarsk (Krasnoyarsk), Russian Federation), N. Gordeeva (Krasnoyarsk (Krasnoyarsk), Russian Federation), I. Soloveva (Krasnoyarsk (Krasnoyarsk), Russian Federation), M. Mamaeva (Krasnoyarsk (Krasnoyarsk), Russian Federation), E. Sobko (Krasnoyarsk (Krasnoyarsk), Russian Federation). Results of vaccination against pneumococcal infection in patients with chronic heart failure. 1771
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Related content which might interest you:
Results of vaccination against pneumococcal infection in patients with chronic lung diseases
Source: International Congress 2019 – Airway infection in COPD
Year: 2019
Effects of pneumococcal vaccine in patients with chronic respiratory disease
Source: Eur Respir Rev 2008; 17: 43-45
Year: 2008
Effects of pneumococcal vaccine in patients with chronic respiratory disease
Source: Annual Congress 2007 - Different aspects of COPD exacerbations
Year: 2007
Analysis of efficiency of joint or consistent vaccination with pneumococcal and influenzal vaccines in patients with chronic obstructive pulmonary disease
Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies
Year: 2019
No preventive effects of 23-valent pneumococcal polysaccharide vaccine in patients with chronic renal failure
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016
Pneumococcal vaccination in chronic respiratory patients – a cohort study
Source: International Congress 2019 – Airway infection in COPD
Year: 2019
Effectiveness of polysaccharide pneumococcal vaccination among subjects with chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 442s
Year: 2006
Inhalative vaccination with pneumococcal polysaccharide in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2007; 30: Suppl. 51, 372s
Year: 2007
Effectiveness of 23-valent pneumococcal polysaccharide vaccine in preventing lower respiratory tract infections complicating chronic respiratory failure
Source: Eur Respir J 2006; 28: Suppl. 50, 576s
Year: 2006
Clinical effect of different pneumococcal vaccination schedules in patients with chronic obstructive pulmonary disease (COPD): long-term follow-up results
Source: International Congress 2017 – What is new in COPD management and prognosis: findings from large studies?
Year: 2017
Prophylactic efficacy of pneumococcal vaccination for chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2006; 28: Suppl. 50, 178s
Year: 2006
Effect of vaccination of pneumococcal infection on the course of chronic obstructive pulmonary disease in combination with diabetes mellitus
Source: International Congress 2019 – Comorbidities in COPD and asthma: body composition and diabetes
Year: 2019
Influenza and pneumococcal vaccines prevalence and their influance on asthma and chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2005; 26: Suppl. 49, 292s
Year: 2005
Influenza and pneumococcal vaccination in patients with COPD
Source: Virtual Congress 2020 – Pharmacological management of COPD
Year: 2020
Determinants of vaccination in patients with community acquired pneumonia (CAP) or chronic lung diseases
Source: Annual Congress 2004 - Community acquired pneumonia - epidemiology and host defence
Year: 2004
Results of treatment of patients with pulmonary tuberculosis combined with HIV infection and hepatitis
Source: International Congress 2018 – Tuberculosis comorbidities
Year: 2018
Risk factors for respiratory failure in pneumococcal pneumonia: the importance of pneumococcal serotypes
Source: Eur Respir J 2014; 43: 545-553
Year: 2013
Efficacy of influenza and pneumococcal vaccinations among patients with COPD
Source: Annual Congress 2007 - Treatment of COPD
Year: 2007
The remaining challenges of pneumococcal disease in adults
Source: Eur Respir Rev 2012; 21: 57-65
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept